Market Cap

Cannasouth Ltd Market Capitalization:

NZ$40.7 Million

NZD as of Jan. 1, 2024

US$25.7 Million

business Cannasouth Ltd Company Profile

Cannasouth Ltd Main Stock Listing

NZX: CBD

Market Capitalization History of Cannasouth Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Cannasouth Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 NZ$40.7 M -6.53%
Jan. 1, 2023 NZ$43.5 M -11.43%
Jan. 1, 2022 NZ$49.2 M -43.55%
Jan. 1, 2021 NZ$87.1 M 21.57%
Jan. 1, 2020 NZ$71.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Cannasouth Ltd Categories

New Zealand languages Healthcare languages Drug Manufacturers—Specialty & Generic
New Zealand Healthcare New Zealand Drug Manufacturers—Specialty & Generic

Stocks & Indices

Cannasouth Ltd has the following listings and related stock indices.


Stock: NZX: CBD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.